Blood Disorders

Hemophilia A and B: Management Guide Topical Map

Complete topic cluster & semantic SEO content plan — 38 articles, 7 content groups  · 

Build a comprehensive, clinician- and patient-focused resource covering diagnosis, acute care, long-term prophylaxis, inhibitors, special populations, and cutting-edge therapies to become the authoritative online destination for hemophilia management. Authority is achieved by deep pillars that synthesize guidelines (WFH, CDC, ISTH), high-quality evidence, practical protocols, and patient-facing how-tos that clinicians, patients, and caregivers actually use.

38 Total Articles
7 Content Groups
25 High Priority
~6 months Est. Timeline

This is a free topical map for Hemophilia A and B: Management Guide. A topical map is a complete topic cluster and semantic SEO strategy that shows every article a site needs to publish to achieve topical authority on a subject in Google. This map contains 38 article titles organised into 7 topic clusters, each with a pillar page and supporting cluster articles — prioritised by search impact and mapped to exact target queries.

How to use this topical map for Hemophilia A and B: Management Guide: Start with the pillar page, then publish the 25 high-priority cluster articles in writing order. Each of the 7 topic clusters covers a distinct angle of Hemophilia A and B: Management Guide — together they give Google complete hub-and-spoke coverage of the subject, which is the foundation of topical authority and sustained organic rankings.

📋 Your Content Plan — Start Here

38 prioritized articles with target queries and writing sequence.

High Medium Low
1

Foundations: Causes, Genetics, and Diagnosis

Covers the biological basis, inheritance, clinical presentation, and diagnostic workup for Hemophilia A and B. This group establishes the essential clinical and genetic knowledge every clinician and informed patient needs.

PILLAR Publish first in this group
Informational 📄 4,200 words 🔍 “hemophilia a and b diagnosis”

Hemophilia A and B: Causes, Genetics, and How They Are Diagnosed

A definitive reference on the pathophysiology and genetics of hemophilia A and B and the step-by-step diagnostic pathway. The article explains inheritance patterns, risk factors, laboratory testing (screening tests, factor assays, inhibitor testing), severity classification, and differential diagnoses, giving clinicians and families a clear diagnostic algorithm and actionable next steps.

Sections covered
What is hemophilia? Types and pathophysiology Genetics and inheritance patterns (X-linked, mutations, carrier status) Clinical presentation: signs and symptoms by age and severity Laboratory evaluation: PT, aPTT, mixing studies, factor VIII/IX assays, Bethesda Severity classification and clinical implications Carrier testing, prenatal diagnosis, and genetic counseling Differential diagnosis: von Willebrand disease, platelet disorders, acquired hemophilia Recommended diagnostic algorithm and referral to Hemophilia Treatment Centers
1
High Informational 📄 900 words

Recognizing hemophilia symptoms by age and severity

Practical guide to the typical bleeding patterns and red flags in neonates, children, adolescents, and adults by severity (severe, moderate, mild). Includes when to seek urgent testing.

🎯 “symptoms of hemophilia”
2
High Informational 📄 1,400 words

Genetic testing and counseling for hemophilia

Explains genetic testing methods, interpreting results, carrier detection, options for prenatal diagnosis, and counseling points for families considering testing.

🎯 “genetic testing for hemophilia”
3
High Informational 📄 1,500 words

Interpreting coagulation labs: aPTT, mixing studies and factor assays

Detailed walkthrough of common coagulation tests, how to interpret prolonged aPTT, the role of mixing studies, and stepwise use of factor assays including pitfalls and pre-analytical issues.

🎯 “aPTT mixing study hemophilia”
4
Medium Informational 📄 1,100 words

Carrier detection and prenatal diagnostic options

Describes carrier testing approaches, noninvasive and invasive prenatal testing options, ethical considerations, and counseling resources.

🎯 “prenatal diagnosis hemophilia”
5
Low Informational 📄 1,000 words

Hemophilia vs von Willebrand disease: how to distinguish them

Compares clinical features and lab patterns of hemophilia and von Willebrand disease, with a testing checklist to avoid misdiagnosis.

🎯 “hemophilia vs von willebrand disease”
2

Acute Bleed Management and Emergency Care

Provides clear, actionable protocols for recognizing and managing acute bleeds, first-aid, emergency department care, and home treatment workflows to reduce morbidity and prevent disability.

PILLAR Publish first in this group
Informational 📄 3,600 words 🔍 “hemophilia bleed management”

Acute Bleed Management and Emergency Protocols for Hemophilia A and B

Comprehensive emergency-focused guide covering first response to bleeding, triage, factor replacement dosing in emergencies, use of desmopressin, special-case management (head injury, compartment syndrome, major trauma), and coordination with Hemophilia Treatment Centers. Includes reproducible ER checklists and sample order sets.

Sections covered
Recognizing and triaging bleeds: mild vs severe Immediate first-aid and home measures Factor replacement in emergencies: dosing tables and infusion timing Use of desmopressin (DDAVP) and contraindications Management of joint bleeds, muscle bleeds, and compartment syndrome Head injury and intracranial hemorrhage protocols Surgical and trauma considerations Emergency documentation, bleed logs, and communication with HTCs
1
High Informational 📄 1,500 words

Home treatment: teaching patients and caregivers to infuse factor

Step-by-step how-to for training patients/caregivers on peripheral venous access, reconstitution, infusion technique, storage, and troubleshooting with safety tips.

🎯 “how to give factor at home”
2
High Informational 📄 1,200 words

Managing joint (hemarthrosis) bleeds: early rehab and long-term prevention

Clinical management plan for hemarthrosis including acute control, icing, immobilization, analgesia, and early physiotherapy to prevent chronic arthropathy.

🎯 “treating hemarthrosis hemophilia”
3
High Informational 📄 1,000 words

Head injuries in people with hemophilia: emergency guidelines

Evidence-based protocols for evaluation, imaging thresholds, factor coverage, observation periods, and neurosurgery coordination after head trauma.

🎯 “head injury hemophilia guidelines”
4
Medium Informational 📄 900 words

Dental procedures and bleeding management in hemophilia

Pre-procedure planning, local measures, factor cover dosages, and when to involve the HTC for extractions and invasive dental care.

🎯 “dental care hemophilia”
5
Low Informational 📄 800 words

Bleed emergency checklist for patients and emergency departments

Printable checklist and sample ED order set to standardize rapid, safe care during a bleeding emergency.

🎯 “bleed emergency checklist hemophilia”
3

Long-term Management and Prophylaxis

Covers strategies to prevent bleeds and long-term complications: prophylaxis regimens, product selection, monitoring, adherence, and orthopedic and rehabilitation care—core content for improving lifelong outcomes.

PILLAR Publish first in this group
Informational 📄 5,200 words 🔍 “hemophilia prophylaxis guide”

Long-term Management and Prophylaxis Strategies for Hemophilia A and B

A comprehensive guide to preventive care including prophylaxis schedules (standard and tailored), comparing factor products (standard vs extended half-life), non-factor prophylaxis (emicizumab), monitoring strategies, adherence optimization, and integrated musculoskeletal care to preserve function and quality of life.

Sections covered
Goals of long-term management and outcome measures Prophylaxis: standard vs individualized regimens Factor products: plasma-derived, recombinant, and extended half-life options Non-factor prophylaxis (e.g., emicizumab) and how it changes care Monitoring therapy effectiveness and safety (troughs, inhibitor surveillance) Adherence strategies and patient education Musculoskeletal health: PT, orthopedics and joint preservation Transitioning from pediatric to adult care
1
High Informational 📄 2,000 words

Prophylaxis vs on-demand treatment: evidence, benefits, and choosing a regimen

Comparative analysis of outcomes with prophylaxis versus on-demand therapy, including bleed rates, joint health, quality of life, and cost-effectiveness considerations.

🎯 “prophylaxis vs on demand hemophilia”
2
High Informational 📄 1,800 words

Guide to factor replacement products and choosing the right one

Detailed review of product classes, pharmacokinetics, dosing implications, storage, safety (infectious risk), and practical selection guidance.

🎯 “factor replacement products hemophilia”
3
High Informational 📄 1,600 words

Emicizumab for hemophilia A: when to use, dosing, monitoring, and safety

Explains the mechanism of emicizumab, indications (with and without inhibitors), administration schedules, lab monitoring nuances, interactions with bypassing agents, and adverse events.

🎯 “emicizumab guide”
4
Medium Informational 📄 1,200 words

Physical therapy and orthopedic management to prevent hemophilic arthropathy

Rehabilitation protocols, exercise recommendations, indications for synovectomy or joint replacement, and long-term orthopedic follow-up strategies.

🎯 “physical therapy hemophilia”
5
Low Informational 📄 900 words

Monitoring, adherence, and telehealth tools for long-term care

Practical tools for tracking bleeds, adherence strategies, and using telemedicine and apps to improve outcomes and communication with HTCs.

🎯 “hemophilia monitoring adherence tools”
4

Inhibitors and Immune Tolerance

Focused coverage of factor inhibitors—their detection, clinical impact, and advanced management including bypassing agents and immune tolerance induction—critical for any authoritative hemophilia program.

PILLAR Publish first in this group
Informational 📄 3,800 words 🔍 “hemophilia inhibitors management”

Diagnosis and Management of Inhibitors in Hemophilia A and B

Authoritative review of inhibitor immunology, risk factors, surveillance protocols, interpretation of Bethesda titers, acute management of bleeds with inhibitors, bypassing agents, and immune tolerance induction strategies with outcomes and decision algorithms.

Sections covered
What are inhibitors and why they matter Risk factors and timing of inhibitor development Screening and diagnostic testing (Bethesda assay, Nijmegen modification) Acute bleed management when inhibitors are present Bypassing agents: rFVIIa and aPCC — use and safety Immune tolerance induction (ITI): protocols and outcomes Surgical and pregnancy considerations with inhibitors Emerging therapies and long-term follow-up
1
High Informational 📄 1,200 words

How inhibitors are diagnosed and monitored (Bethesda assay explained)

Explains assay methodology, interpreting low- vs high-titre results, timing of testing, and laboratory pitfalls for accurate inhibitor surveillance.

🎯 “bethesda assay hemophilia”
2
High Informational 📄 1,400 words

Bypassing agents: rFVIIa and aPCC — indications, dosing, and safety

Clinical guide to selecting and dosing bypassing agents for acute bleeds and perioperative coverage, including thrombotic risk mitigation and monitoring.

🎯 “bypassing agents hemophilia”
3
High Informational 📄 1,500 words

Immune tolerance induction (ITI): protocols, outcomes, and patient selection

Detailed review of ITI approaches, success predictors, duration, adverse effects, and how to counsel families on expectations.

🎯 “immune tolerance induction hemophilia”
4
Medium Informational 📄 1,000 words

Managing surgery and invasive procedures in patients with inhibitors

Perioperative planning, hemostatic strategies using bypassing agents or combined approaches, and postoperative monitoring recommendations.

🎯 “surgery hemophilia inhibitors”
5

Special Populations: Pediatrics, Women, Pregnancy, and Aging

Tailors management principles to newborns, children, women/carriers, pregnant patients, and older adults—addressing unique risks, monitoring, and life-stage transitions.

PILLAR Publish first in this group
Informational 📄 3,400 words 🔍 “hemophilia management across lifespan”

Managing Hemophilia Across the Lifespan: Pediatrics, Women, Pregnancy, and Aging

Comprehensive lifecycle guidance including newborn assessment and prophylaxis initiation, school and activity advice for children, bleeding management in female carriers and pregnant persons, contraception and obstetric planning, and care priorities for aging patients with comorbidities.

Sections covered
Newborn and infant management: diagnosis, circumcision, and early prophylaxis Pediatric prophylaxis initiation and developmental considerations Bleeding symptoms and management in female carriers and affected women Pregnancy, delivery, and postpartum management Contraception and gynecologic bleeding management Transitioning adolescent patients to adult care Aging with hemophilia: comorbidity management and joint replacement
1
High Informational 📄 1,500 words

Pregnancy and delivery in carriers and women with hemophilia: guidelines for obstetricians and patients

Obstetric management plan including antepartum testing, peripartum factor management, neuraxial anesthesia considerations, and postpartum hemorrhage prevention.

🎯 “pregnancy hemophilia management”
2
High Informational 📄 1,000 words

Hemophilia in newborns and infants: detection and early-care strategies

Immediate postnatal evaluation, safe vaccination and circumcision guidance, when to start prophylaxis, and parental education resources.

🎯 “newborn hemophilia care”
3
Medium Informational 📄 1,000 words

Bleeding symptoms and management in female carriers

Assessment and treatment strategies for symptomatic carriers including lab thresholds, tranexamic acid use, and collaboration with hematology.

🎯 “female carriers hemophilia bleeding”
4
Low Informational 📄 1,200 words

Aging with hemophilia: managing comorbidities and joint replacement

Addresses cardiovascular risk, osteoporosis, polypharmacy, indications and perioperative strategies for orthopedic surgery in older adults with hemophilia.

🎯 “aging with hemophilia”
6

Advanced Therapies, Clinical Trials, and Research

Explains gene therapy, novel non-factor agents, the clinical trial landscape, and evidence for new therapeutic approaches to position the site as up-to-date on cutting-edge care.

PILLAR Publish first in this group
Informational 📄 3,600 words 🔍 “gene therapy hemophilia latest”

Advanced and Emerging Therapies for Hemophilia A and B: Gene Therapy, Non-Factor Agents, and Trials

In-depth review of approved and investigational advanced therapies including AAV-based gene therapy, RNAi and other non-factor approaches, long-term efficacy and safety data, patient eligibility, and practical considerations for counseling and access to trials.

Sections covered
Overview of gene therapy approaches for hemophilia A and B Current approved products and regulatory status (by region) Eligibility, screening, and pre-treatment workup for gene therapy Non-factor therapies: siRNA, anti-TFPI, and monoclonal strategies Clinical trial landscape and how to find trials Safety, durability, and long-term monitoring post-gene therapy Cost, access, and ethical considerations
1
High Informational 📄 2,000 words

Gene therapy for hemophilia A and B: mechanism, outcomes, and who is eligible

Explains AAV-based gene transfer, summary of trial outcomes and approvals, inclusion/exclusion criteria, pre-treatment counseling checklist, and real-world follow-up needs.

🎯 “gene therapy for hemophilia eligibility”
2
High Informational 📄 1,500 words

Non-factor therapies in development: fitusiran, concizumab, and others

Mechanisms, clinical data, dosing concepts, bleeding outcomes, and safety profiles for major non-factor agents under development or approved.

🎯 “non-factor therapy hemophilia”
3
Medium Informational 📄 900 words

How to find, evaluate, and enroll in hemophilia clinical trials

Practical guide to trial registries, eligibility screening, informed consent, risk–benefit conversations, and working with HTCs and trial sites.

🎯 “hemophilia clinical trials how to join”
4
Low Informational 📄 1,000 words

Cost, access, and insurance considerations for advanced hemophilia therapies

Analyzes pricing models, payer pathways, prior authorization, patient assistance programs, and long-term economic considerations for gene therapy and high-cost agents.

🎯 “cost of gene therapy hemophilia”
7

Practical Living, Care Coordination, and Resources

Practical, non-clinical content on living well with hemophilia—navigating HTCs, insurance, school/work accommodations, registries, and psychosocial support to improve real-world outcomes.

PILLAR Publish first in this group
Informational 📄 2,600 words 🔍 “living with hemophilia resources”

Living with Hemophilia: Care Coordination, Insurance, Education, and Support Resources

A pragmatic guide for patients and caregivers covering how to choose and work with a Hemophilia Treatment Center, navigate insurance and high-cost therapy authorization, school and workplace accommodations, travel and sports safety, and where to find credible support organizations and registries.

Sections covered
Role of Hemophilia Treatment Centers and how to choose one Insurance, prior authorization, and managing high-cost therapies School, sports, and workplace accommodations and individualized plans Travel and emergency preparedness for people with hemophilia Mental health, family support, and peer groups Registries and reporting outcomes (ATHN, WFH, national registries) Practical templates: emergency card, bleed log, letter for school/employer
1
High Informational 📄 900 words

How to choose and work with a Hemophilia Treatment Center (HTC)

Explains multidisciplinary services HTCs offer, questions to ask, and how to coordinate care between local providers and the HTC.

🎯 “choose hemophilia treatment center”
2
High Informational 📄 1,200 words

Navigating insurance, prior authorization, and financial assistance for factor and advanced therapies

Practical steps to secure coverage, prepare documentation, appeal denials, and access manufacturer or nonprofit assistance programs.

🎯 “insurance for hemophilia treatments”
3
Medium Informational 📄 800 words

School and workplace accommodation templates and safety plans

Downloadable templates and best-practice guidance for individualized healthcare plans, 504 plans, and workplace accommodations.

🎯 “school plan hemophilia”
4
Low Informational 📄 700 words

Support organizations, registries, and patient advocacy resources

Directory of leading global and national organizations, registries, helplines, and counseling resources with tips on when to contact each.

🎯 “hemophilia support organizations”

Content Strategy for Hemophilia A and B: Management Guide

The recommended SEO content strategy for Hemophilia A and B: Management Guide is the hub-and-spoke topical map model: one comprehensive pillar page on Hemophilia A and B: Management Guide, supported by 31 cluster articles each targeting a specific sub-topic. This gives Google the complete hub-and-spoke coverage it needs to rank your site as a topical authority on Hemophilia A and B: Management Guide — and tells it exactly which article is the definitive resource.

38

Articles in plan

7

Content groups

25

High-priority articles

~6 months

Est. time to authority

What to Write About Hemophilia A and B: Management Guide: Complete Article Index

Every blog post idea and article title in this Hemophilia A and B: Management Guide topical map — 0+ articles covering every angle for complete topical authority. Use this as your Hemophilia A and B: Management Guide content plan: write in the order shown, starting with the pillar page.

Full article library generating — check back shortly.

This topical map is part of IBH's Content Intelligence Library — built from insights across 100,000+ articles published by 25,000+ authors on IndiBlogHub since 2017.

Find your next topical map.

Hundreds of free maps. Every niche. Every business type. Every location.